Technology | Magnetic Resonance Imaging (MRI) | January 06, 2017

FDA-cleared cS Edition engineered for more efficient and standardized cardiac exams

Toshiba, Vantage Titan 1.5T cS Edition, MRI, RSNA 2016, cardiac exams, FDA clearance

January 6, 2017 — Toshiba Medical announced in November that its Vantage Titan 1.5T/cS Edition magnetic resonance imaging (MRI) system with M-Power V3.6 software received U.S. Food and Drug Administration (FDA) clearance at the 2016 annual meeting of the Radiological Society of North America (RSNA). The new system retains all the patient-friendly features of the Vantage Titan 1.5T MR with added technology to simplify complex cardiac exams.

The Vantage Titan / cS Edition offers cardiologists and radiologists a comprehensive suite of innovative applications to help them improve their workflow and patient comfort:

  • SUREVOI with CardioLine+ (Option): The system offers SUREVOI Cardiac anatomy recognition technology to automatically determine the position of the heart. The enhanced CardioLine application CardioLine+ works with SUREVOI to automatically detect anatomical landmarks for accurate and reproducible positioning to complete alignment of 14 standard cardiac views with minimal operator interaction;
  • Multi b-Value Diffusion: The Vantage Titan / cS Edition allows acquisition of multiple b-values in a single scan enabling physicians to quickly identify tissue diffusivity;
  • Multi-echo T2 Mapping: The system also supports Multi-echo T2 Mapping, enabling physicians to visualize T2 map cartilage images to aid them in making a diagnosis and determining if treatment is needed; and
  • Vitrea Extend (Option): The Vitrea Extend application permits clinicians to complete post-processing at a separate workstation while allowing the next patient exam to be conducted at the magnetic resonance (MR) system. The Vitrea Extend solution comes with expert packages powered by the latest post-processing applications made by Olea Medical and Medis.

For more information: www.medical.toshiba.com


Related Content

News | Cardiac Imaging

May 20, 2025 — Royal Philips has launched the RADIQAL (Radiation Dose and Image Quality Trial) trial. This multicenter ...

Time May 27, 2025
arrow
News | Pediatric Imaging

May 13, 2025-- GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric ...

Time May 20, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
Subscribe Now